I G Ron
Overview
Explore the profile of I G Ron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kemeny N, Ron I
Semin Oncol
. 1999 Oct;
26(5):524-35.
PMID: 10528900
Hepatic metastases are a major cause of morbidity and mortality for patients with colorectal cancer (CRC). The rationale for hepatic arterial chemotherapy has both an anatomical and pharmacological basis. Several...
12.
Fata F, Ron I, Kemeny N, OReilly E, Klimstra D, Kelsen D
Cancer
. 1999 Oct;
86(7):1129-34.
PMID: 10506695
Background: Diarrhea and oral mucositis are the most frequently reported gastrointestinal side effects caused by 5-fluorouracil (5-FU). Diarrhea may be severe in 10-30% of patients and is schedule-dependent. 5-FU-induced gastrointestinal...
13.
Ron I, Vishne T, Kraminsky N, Bar-Am A, Inbar M
Am J Clin Oncol
. 1999 Feb;
22(1):35-7.
PMID: 10025377
A phase II study of carboplatin and etoposide as salvage polychemotherapy in metastatic, infiltrating breast carcinoma was carried out with 25 multiply pretreated patients. Six of 25 patients (24%) had...
14.
Ron I, Striecker A, Lerman H, Bar-Am A, Frisch B
Oncol Rep
. 1998 Dec;
6(1):185-8.
PMID: 9864425
This study provides the first quantitative indication of the limits of sensitivity of a bone scan with technetium (99Tc-MDP) in detecting skeletal metastases and thereby also helps to explain the...
15.
Vishne T, Ron I
Am J Clin Oncol
. 1998 Dec;
21(6):602-4.
PMID: 9856663
The authors report the cases of two patients in whom strontium-89 (89Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself...
16.
Ron I, Peleg L, Rienstein S, Dotan A, Ticher A, Wolfson S, et al.
Cancer Chemother Pharmacol
. 1998 Jul;
42(2):135-41.
PMID: 9654113
A growing body of data suggests that cancer therapy may be improved and toxicity reduced by administration of antineoplastic agents and cytokines at carefully selected times of the day. The...
17.
Bar-Am A, Ron I, Kuperminc M, Gal I, Jaffa A, Kovner F, et al.
Acta Obstet Gynecol Scand
. 1998 Apr;
77(3):347-50.
PMID: 9539285
Background And Methods: The cases of 245 patients diagnosed during 1980-1989 with stage I endometrial carcinoma were retrospectively reviewed in order to assess the contribution of lymph node sampling (LNS)...
18.
Ron I, Kalmus Y, Kalmus Z, Inbar M, Chaitchik S
Support Care Cancer
. 1997 Mar;
5(2):136-8.
PMID: 9069614
To assess any difference in the incidence of alopecia during treatment and of skull metastases during follow-up among breast cancer patients undergoing scalp cooling during chemotherapy and those treated at...
19.
Barak Y, Ron I, Sirota P, Sobe T, Slor H
Int Clin Psychopharmacol
. 1996 Sep;
11(3):193-7.
PMID: 8923098
The ability of human cells to repair DNA damage can be indirectly assessed by measuring transcriptional activity relating to active genes, a process referred to as RNA synthesis. This study...
20.
Inbar M, Ron I
Acta Obstet Gynecol Scand
. 1996 Sep;
75(8):765-7.
PMID: 8906015
No abstract available.